Meilahti Vaccine Research Center, Helsinki University Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kantele, Anu
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Recruiting
4
60
Europe
Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral®
Helsinki University Central Hospital, University of Helsinki
Vaccine-Preventable Diseases, Typhoid Fever, Cholera
12/25
12/25
CP_COVID-19, NCT04730401: Convalescent Plasma in the Treatment of Covid-19

Active, not recruiting
2
390
Europe
Convalescent plasma from COVID-19 donors, Placebo
Helsinki University Central Hospital, Finnish Red Cross
Covid19
01/22
01/23
Pakkanen, Sari
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Recruiting
4
60
Europe
Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral®
Helsinki University Central Hospital, University of Helsinki
Vaccine-Preventable Diseases, Typhoid Fever, Cholera
12/25
12/25
FMT-UTI, NCT06050148: Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Recruiting
2/3
100
Europe
Feacal microbial transplantation (FMT), Placebo transplantation (PT)
Helsinki University Central Hospital, University of Helsinki
Recurrent Urinary Tract Infection
12/28
12/29
Riekkinen, Marianna
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Recruiting
4
60
Europe
Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral®
Helsinki University Central Hospital, University of Helsinki
Vaccine-Preventable Diseases, Typhoid Fever, Cholera
12/25
12/25

Download Options